FindTrial
Sign In

Creating and Testing a Patient Information Leaflet in a Local Language for Selected Oral Anti-Cancer Drugs in the Oncology Department Information Leaflet in Regional Language for selected Oral Anti-cancer drugs in Oncology Department.

Development, Validation and Evaluation of Effectiveness of Patient Information Leaflet in Regional Language for selected Oral Anti-cancer drugs in Oncology Department. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/082728
Enrollment
50
Registered
2025-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Control Intervention1: Nil: Nil

Sponsors

Shree krishna hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are histologically and Cytologically diagnosed with malignancy. Adult patients 18 years or above. Patients willing to provide informed consent to participate in the study. Patients who are receiving selected oral drugs such as Capecitabine, Gefitinib, Palbociclib and Lenalidomide in the oncology department of the tertiary care hospital.

Exclusion criteria

Exclusion criteria: Patients with cognitive impairments affecting their ability to comprehend written materials. Patients who are not fluent in the Gujarati language. Patients currently participating in other interventional studies that might influence the outcomes.

Design outcomes

Primary

MeasureTime frame
To develop patient information leaflet in Gujarati language. To validate the prepared patient information leaflet. To assess the effectiveness of patient information leaflets (PILs) in Gujarati language and understand adherence among patient using PILs.Timepoint: 6 months—

Secondary

MeasureTime frame
To evaluate patient satisfaction with the PILs.Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr Nirav Asarawala
niravna@charutarhealth.org9825744593

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026